Related references
Note: Only part of the references are listed.Burden and cost of neurological diseases: a European North-South comparison
A. Raggi et al.
ACTA NEUROLOGICA SCANDINAVICA (2015)
Effect of Methylprednisolone on Mammalian Neuronal Networks In Vitro
Matthias Wittstock et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2015)
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity
F. Kamin et al.
SPINAL CORD (2015)
Spasticity in patients with multiple sclerosis - clinical characteristics, treatment and quality of life
P. Flachenecker et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
Costs and quality of life in multiple sclerosis patients with spasticity
J. Svensson et al.
ACTA NEUROLOGICA SCANDINAVICA (2014)
A Difficult Case to Swallow: Herpes Esophagitis After Epidural Steroid Injection
Kelli Davis et al.
AMERICAN JOURNAL OF THERAPEUTICS (2014)
Nabiximols (THC/CBD Oromucosal Spray, Sativex (R)) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity
Peter Flachenecker et al.
EUROPEAN NEUROLOGY (2014)
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis
Irene Moreno Torres et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2014)
Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
Lukas Haider et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Effects of Repeated Intrathecal Triamcinolone-Acetonide Application on Cerebrospinal Fluid Biomarkers of Axonal Damage and Glial Activity in Multiple Sclerosis Patients
P. S. Rommer et al.
MOLECULAR DIAGNOSIS & THERAPY (2014)
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I)
Uwe K. Zettl et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2014)
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
Owain W. Howell et al.
BRAIN (2011)
Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis
Howard L. Zwibel
ADVANCES IN THERAPY (2009)
Repeat intrathecal triamcinolone acetonide application is beneficial in progressive MS patients
V Hoffmann et al.
EUROPEAN JOURNAL OF NEUROLOGY (2006)
Prevalence and treatment of spasticity reported by multiple sclerosis patients
MA Rizzo et al.
MULTIPLE SCLEROSIS (2004)
Efficacy and safety of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients
V Hoffmann et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2003)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
Intraspinal steroids: history, efficacy, accidentality, and controversy with review of United States Food and Drug Administration reports
DA Nelson et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Share Paper
